Global Cancer Screening Sales Market Report 2016

Publisher Name :
Date: 11-Oct-2016
No. of pages: 121
Inquire Before Buying

Notes:

Sales, means the sales volume of Cancer Screening

Revenue, means the sales value of Cancer Screening

This report studies sales (consumption) of Cancer Screening in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Abbott

- Roche

- Fujirebio Diagnostics, Inc.

- BioMérieux

- Beckman Coulter

- Clarient

- Siemens

- DiaSorin

- Qiagen

- Xeptagen

- Orion Genomics.

- Hologic, Inc.

- Quest Diagnostics

- Oncohealth Corporation

- Femasys, Inc.

- Biohit Oyj

- Sysmex

- Immunostics

- Alere

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Cancer Screening in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Cancer Screening in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Cancer Screening Sales Market Report 2016

Table of Contents
Global Cancer Screening Sales Market Report 2016
1 Cancer Screening Overview
1.1 Product Overview and Scope of Cancer Screening
1.2 Classification of Cancer Screening
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Cancer Screening
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Cancer Screening Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Cancer Screening (2011-2021)
1.5.1 Global Cancer Screening Sales and Growth Rate (2011-2021)
1.5.2 Global Cancer Screening Revenue and Growth Rate (2011-2021)
2 Global Cancer Screening Competition by Manufacturers, Type and Application
2.1 Global Cancer Screening Market Competition by Manufacturers
2.1.1 Global Cancer Screening Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Cancer Screening Revenue and Share by Manufacturers (2011-2016)
2.2 Global Cancer Screening (Volume and Value) by Type
2.2.1 Global Cancer Screening Sales and Market Share by Type (2011-2016)
2.2.2 Global Cancer Screening Revenue and Market Share by Type (2011-2016)
2.3 Global Cancer Screening (Volume and Value) by Regions
2.3.1 Global Cancer Screening Sales and Market Share by Regions (2011-2016)
2.3.2 Global Cancer Screening Revenue and Market Share by Regions (2011-2016)
2.4 Global Cancer Screening (Volume) by Application
3 USA Cancer Screening (Volume, Value and Sales Price)
3.1 USA Cancer Screening Sales and Value (2011-2016)
3.1.1 USA Cancer Screening Sales and Growth Rate (2011-2016)
3.1.2 USA Cancer Screening Revenue and Growth Rate (2011-2016)
3.1.3 USA Cancer Screening Sales Price Trend (2011-2016)
3.2 USA Cancer Screening Sales and Market Share by Manufacturers
3.3 USA Cancer Screening Sales and Market Share by Type
3.4 USA Cancer Screening Sales and Market Share by Application
4 China Cancer Screening (Volume, Value and Sales Price)
4.1 China Cancer Screening Sales and Value (2011-2016)
4.1.1 China Cancer Screening Sales and Growth Rate (2011-2016)
4.1.2 China Cancer Screening Revenue and Growth Rate (2011-2016)
4.1.3 China Cancer Screening Sales Price Trend (2011-2016)
4.2 China Cancer Screening Sales and Market Share by Manufacturers
4.3 China Cancer Screening Sales and Market Share by Type
4.4 China Cancer Screening Sales and Market Share by Application
5 Europe Cancer Screening (Volume, Value and Sales Price)
5.1 Europe Cancer Screening Sales and Value (2011-2016)
5.1.1 Europe Cancer Screening Sales and Growth Rate (2011-2016)
5.1.2 Europe Cancer Screening Revenue and Growth Rate (2011-2016)
5.1.3 Europe Cancer Screening Sales Price Trend (2011-2016)
5.2 Europe Cancer Screening Sales and Market Share by Manufacturers
5.3 Europe Cancer Screening Sales and Market Share by Type
5.4 Europe Cancer Screening Sales and Market Share by Application
6 Japan Cancer Screening (Volume, Value and Sales Price)
6.1 Japan Cancer Screening Sales and Value (2011-2016)
6.1.1 Japan Cancer Screening Sales and Growth Rate (2011-2016)
6.1.2 Japan Cancer Screening Revenue and Growth Rate (2011-2016)
6.1.3 Japan Cancer Screening Sales Price Trend (2011-2016)
6.2 Japan Cancer Screening Sales and Market Share by Manufacturers
6.3 Japan Cancer Screening Sales and Market Share by Type
6.4 Japan Cancer Screening Sales and Market Share by Application
7 India Cancer Screening (Volume, Value and Sales Price)
7.1 India Cancer Screening Sales and Value (2011-2016)
7.1.1 India Cancer Screening Sales and Growth Rate (2011-2016)
7.1.2 India Cancer Screening Revenue and Growth Rate (2011-2016)
7.1.3 India Cancer Screening Sales Price Trend (2011-2016)
7.2 India Cancer Screening Sales and Market Share by Manufacturers
7.3 India Cancer Screening Sales and Market Share by Type
7.4 India Cancer Screening Sales and Market Share by Application
8 Southeast Asia Cancer Screening (Volume, Value and Sales Price)
8.1 Southeast Asia Cancer Screening Sales and Value (2011-2016)
8.1.1 Southeast Asia Cancer Screening Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Cancer Screening Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Cancer Screening Sales Price Trend (2011-2016)
8.2 Southeast Asia Cancer Screening Sales and Market Share by Manufacturers
8.3 Southeast Asia Cancer Screening Sales and Market Share by Type
8.4 Southeast Asia Cancer Screening Sales and Market Share by Application
9 Global Cancer Screening Manufacturers Analysis
9.1 Abbott
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Cancer Screening Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Abbott Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Roche
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 121 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Roche Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Fujirebio Diagnostics, Inc.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 143 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Fujirebio Diagnostics, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 BioMérieux
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Oct Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 BioMérieux Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Beckman Coulter
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Beckman Coulter Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Clarient
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Clarient Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Siemens
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharmaceuticals Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Siemens Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 DiaSorin
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 DiaSorin Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Qiagen
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Qiagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 Xeptagen
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 Xeptagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Orion Genomics.
9.12 Hologic, Inc.
9.13 Quest Diagnostics
9.14 Oncohealth Corporation
9.15 Femasys, Inc.
9.16 Biohit Oyj
9.17 Sysmex
9.18 Immunostics
9.19 Alere
10 Cancer Screening Maufacturing Cost Analysis
10.1 Cancer Screening Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Cancer Screening
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Cancer Screening Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Cancer Screening Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Cancer Screening Market Forecast (2016-2021)
14.1 Global Cancer Screening Sales, Revenue Forecast (2016-2021)
14.2 Global Cancer Screening Sales Forecast by Regions (2016-2021)
14.3 Global Cancer Screening Sales Forecast by Type (2016-2021)
14.4 Global Cancer Screening Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Cancer Screening
Table Classification of Cancer Screening
Figure Global Sales Market Share of Cancer Screening by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Cancer Screening
Figure Global Sales Market Share of Cancer Screening by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Cancer Screening Revenue and Growth Rate (2011-2021)
Figure China Cancer Screening Revenue and Growth Rate (2011-2021)
Figure Europe Cancer Screening Revenue and Growth Rate (2011-2021)
Figure Japan Cancer Screening Revenue and Growth Rate (2011-2021)
Figure India Cancer Screening Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Cancer Screening Revenue and Growth Rate (2011-2021)
Figure Global Cancer Screening Sales and Growth Rate (2011-2021)
Figure Global Cancer Screening Revenue and Growth Rate (2011-2021)
Table Global Cancer Screening Sales of Key Manufacturers (2011-2016)
Table Global Cancer Screening Sales Share by Manufacturers (2011-2016)
Figure 2015 Cancer Screening Sales Share by Manufacturers
Figure 2016 Cancer Screening Sales Share by Manufacturers
Table Global Cancer Screening Revenue by Manufacturers (2011-2016)
Table Global Cancer Screening Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Cancer Screening Revenue Share by Manufacturers
Table 2016 Global Cancer Screening Revenue Share by Manufacturers
Table Global Cancer Screening Sales and Market Share by Type (2011-2016)
Table Global Cancer Screening Sales Share by Type (2011-2016)
Figure Sales Market Share of Cancer Screening by Type (2011-2016)
Figure Global Cancer Screening Sales Growth Rate by Type (2011-2016)
Table Global Cancer Screening Revenue and Market Share by Type (2011-2016)
Table Global Cancer Screening Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Screening by Type (2011-2016)
Figure Global Cancer Screening Revenue Growth Rate by Type (2011-2016)
Table Global Cancer Screening Sales and Market Share by Regions (2011-2016)
Table Global Cancer Screening Sales Share by Regions (2011-2016)
Figure Sales Market Share of Cancer Screening by Regions (2011-2016)
Figure Global Cancer Screening Sales Growth Rate by Regions (2011-2016)
Table Global Cancer Screening Revenue and Market Share by Regions (2011-2016)
Table Global Cancer Screening Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Cancer Screening by Regions (2011-2016)
Figure Global Cancer Screening Revenue Growth Rate by Regions (2011-2016)
Table Global Cancer Screening Sales and Market Share by Application (2011-2016)
Table Global Cancer Screening Sales Share by Application (2011-2016)
Figure Sales Market Share of Cancer Screening by Application (2011-2016)
Figure Global Cancer Screening Sales Growth Rate by Application (2011-2016)
Figure USA Cancer Screening Sales and Growth Rate (2011-2016)
Figure USA Cancer Screening Revenue and Growth Rate (2011-2016)
Figure USA Cancer Screening Sales Price Trend (2011-2016)
Table USA Cancer Screening Sales by Manufacturers (2011-2016)
Table USA Cancer Screening Market Share by Manufacturers (2011-2016)
Table USA Cancer Screening Sales by Type (2011-2016)
Table USA Cancer Screening Market Share by Type (2011-2016)
Table USA Cancer Screening Sales by Application (2011-2016)
Table USA Cancer Screening Market Share by Application (2011-2016)
Figure China Cancer Screening Sales and Growth Rate (2011-2016)
Figure China Cancer Screening Revenue and Growth Rate (2011-2016)
Figure China Cancer Screening Sales Price Trend (2011-2016)
Table China Cancer Screening Sales by Manufacturers (2011-2016)
Table China Cancer Screening Market Share by Manufacturers (2011-2016)
Table China Cancer Screening Sales by Type (2011-2016)
Table China Cancer Screening Market Share by Type (2011-2016)
Table China Cancer Screening Sales by Application (2011-2016)
Table China Cancer Screening Market Share by Application (2011-2016)
Figure Europe Cancer Screening Sales and Growth Rate (2011-2016)
Figure Europe Cancer Screening Revenue and Growth Rate (2011-2016)
Figure Europe Cancer Screening Sales Price Trend (2011-2016)
Table Europe Cancer Screening Sales by Manufacturers (2011-2016)
Table Europe Cancer Screening Market Share by Manufacturers (2011-2016)
Table Europe Cancer Screening Sales by Type (2011-2016)
Table Europe Cancer Screening Market Share by Type (2011-2016)
Table Europe Cancer Screening Sales by Application (2011-2016)
Table Europe Cancer Screening Market Share by Application (2011-2016)
Figure Japan Cancer Screening Sales and Growth Rate (2011-2016)
Figure Japan Cancer Screening Revenue and Growth Rate (2011-2016)
Figure Japan Cancer Screening Sales Price Trend (2011-2016)
Table Japan Cancer Screening Sales by Manufacturers (2011-2016)
Table Japan Cancer Screening Market Share by Manufacturers (2011-2016)
Table Japan Cancer Screening Sales by Type (2011-2016)
Table Japan Cancer Screening Market Share by Type (2011-2016)
Table Japan Cancer Screening Sales by Application (2011-2016)
Table Japan Cancer Screening Market Share by Application (2011-2016)
Figure India Cancer Screening Sales and Growth Rate (2011-2016)
Figure India Cancer Screening Revenue and Growth Rate (2011-2016)
Figure India Cancer Screening Sales Price Trend (2011-2016)
Table India Cancer Screening Sales by Manufacturers (2011-2016)
Table India Cancer Screening Market Share by Manufacturers (2011-2016)
Table India Cancer Screening Sales by Type (2011-2016)
Table India Cancer Screening Market Share by Type (2011-2016)
Table India Cancer Screening Sales by Application (2011-2016)
Table India Cancer Screening Market Share by Application (2011-2016)
Figure Southeast Asia Cancer Screening Sales and Growth Rate (2011-2016)
Figure Southeast Asia Cancer Screening Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Cancer Screening Sales Price Trend (2011-2016)
Table Southeast Asia Cancer Screening Sales by Manufacturers (2011-2016)
Table Southeast Asia Cancer Screening Market Share by Manufacturers (2011-2016)
Table Southeast Asia Cancer Screening Sales by Type (2011-2016)
Table Southeast Asia Cancer Screening Market Share by Type (2011-2016)
Table Southeast Asia Cancer Screening Sales by Application (2011-2016)
Table Southeast Asia Cancer Screening Market Share by Application (2011-2016)
Table Abbott Basic Information List
Table Abbott Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Cancer Screening Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Cancer Screening Global Market Share (2011-2016)
Table Fujirebio Diagnostics, Inc. Basic Information List
Table Fujirebio Diagnostics, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Fujirebio Diagnostics, Inc. Cancer Screening Global Market Share (2011-2016)
Table BioMérieux Basic Information List
Table BioMérieux Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BioMérieux Cancer Screening Global Market Share (2011-2016)
Table Beckman Coulter Basic Information List
Table Beckman Coulter Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Beckman Coulter Cancer Screening Global Market Share (2011-2016)
Table Clarient Basic Information List
Table Clarient Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Clarient Cancer Screening Global Market Share (2011-2016)
Table Siemens Basic Information List
Table Siemens Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Siemens Cancer Screening Global Market Share (2011-2016)
Table DiaSorin Basic Information List
Table DiaSorin Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure DiaSorin Cancer Screening Global Market Share (2011-2016)
Table Qiagen Basic Information List
Table Qiagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Qiagen Cancer Screening Global Market Share (2011-2016)
Table Xeptagen Basic Information List
Table Xeptagen Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Xeptagen Cancer Screening Global Market Share (2011-2016)
Table Orion Genomics. Basic Information List
Table Orion Genomics. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Orion Genomics. Cancer Screening Global Market Share (2011-2016)
Table Hologic, Inc. Basic Information List
Table Hologic, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hologic, Inc. Cancer Screening Global Market Share (2011-2016)
Table Quest Diagnostics Basic Information List
Table Quest Diagnostics Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Quest Diagnostics Cancer Screening Global Market Share (2011-2016)
Table Oncohealth Corporation Basic Information List
Table Oncohealth Corporation Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Oncohealth Corporation Cancer Screening Global Market Share (2011-2016)
Table Femasys, Inc. Basic Information List
Table Femasys, Inc. Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Femasys, Inc. Cancer Screening Global Market Share (2011-2016)
Table Biohit Oyj Basic Information List
Table Biohit Oyj Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biohit Oyj Cancer Screening Global Market Share (2011-2016)
Table Sysmex Basic Information List
Table Sysmex Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sysmex Cancer Screening Global Market Share (2011-2016)
Table Immunostics Basic Information List
Table Immunostics Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Immunostics Cancer Screening Global Market Share (2011-2016)
Table Alere Basic Information List
Table Alere Cancer Screening Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alere Cancer Screening Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Screening
Figure Manufacturing Process Analysis of Cancer Screening
Figure Cancer Screening Industrial Chain Analysis
Table Raw Materials Sources of Cancer Screening Major Manufacturers in 2015
Table Major Buyers of Cancer Screening
Table Distributors/Traders List
Figure Global Cancer Screening Sales and Growth Rate Forecast (2016-2021)
Figure Global Cancer Screening Revenue and Growth Rate Forecast (2016-2021)
Table Global Cancer Screening Sales Forecast by Regions (2016-2021)
Table Global Cancer Screening Sales Forecast by Type (2016-2021)
Table Global Cancer Screening Sales Forecast by Application (2016-2021)
  • Therapies for Resistant and Recurrent Metastatic Cancer
    Published: 06-Nov-2017        Price: US 4950 Onwards        Pages: 338
    The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022. The lung cancer market is expected to grow from $15.7 billion in 2017 to $22.6 billion in 2022 at a CAGR of 7.6% for the period 2017-2022. The stomach cancer segment of the global cancer therapeutics market is expected to grow from $8.2 billion in 2017 to $11.9 billion in 2022 at a CAGR of 7.7% for the period 2017-20......
  • Healthcare Analytics: Technologies and Global Markets
    Published: 31-Oct-2017        Price: US 4950 Onwards        Pages: 105
    The global market for healthcare analytics reached $6.2 billion in 2016. This market should reach nearly $7.2 billion in 2017 and $14.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.8%. The financial analytics market segment is projected to grow from $3.0 billion in 2017 to nearly $5.3 billion in 2020 at a CAGR of 11.9% for the period 2017-2022. The clinical analytics market segment is expected to grow from nearly $2.8 billion in 2017 to $6.2 billion by 2022, incre......
  • Medication Adherence: Systems, Technologies and Global Markets
    Published: 09-Oct-2017        Price: US 4950 Onwards        Pages: 166
    The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021. United States market for medication adherence is expected to grow from $954 million in 2016 to nearly $2.1 billion at a CAGR of 17.5% from 2016 through 2021. Asia market for medication adherence is expected to grow from $225 million in 2016 to $555 million in 2021 at a CAGR of 19.8% from 2016 th......
  • Biologic and Medical Imaging Reagents: Global Markets
    Published: 05-Oct-2017        Price: US 4950 Onwards        Pages: 286
    The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022. The radioactive imaging market will grow from $4.2 billion in 2017 to nearly $8.4 billion by 2022 with a CAGR of 14.7%. The optical imaging market will grow from $4.9 billion in 2017 to around $7.9 billion by 2022 with a CAGR of 9.8%.......
  • Nanotechnology in Medical Applications: The Global Market
    Published: 29-Sep-2017        Price: US 4950 Onwards        Pages: 121
    The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017 through 2022 and should reach $293.1 billion by 2022 from $151.9 billion in 2017. Nanomedicine market for anticancers is projected to grow at a CAGR of 12.3% from 2017 to 2022, and should reach $84.4 billion by 2022 from $47.3 billion in 2017. Nanomedicine market for CNS products is projected to grow at a CAGR of 18.2% and s......
  • Medical Device Security: Technologies and Global Markets
    Published: 27-Sep-2017        Price: US 5500 Onwards        Pages: 140
    The global market for medical device security totaled $4.7 billion in 2016. The market should total $5.2 billion in 2017 and $7.5 billion by 2022, increasing at a compound annual growth rate (CAGR) 7.4% from 2017 to 2022. The hardware segment market for medical device security totaled $2.8 billion in 2016. The market should total over $3.0 billion in 2017 and $4.2 billion by 2022, increasing at a CAGR of 6.7% from 2017 to 2022. The software segment market for medical device securit......
  • Disposable Medical Sensors: Technologies and Global Markets
    Published: 13-Sep-2017        Price: US 4950 Onwards        Pages: 147
    The global market for disposable medical sensors reached $5.1 billion in 2016. The market should reach $5.6 billion in 2017 and $9.0 billion by 2022, at a five-year compound annual growth rate (CAGR) of 10.0% from 2017 to 2022. The North American disposable medical sensors market should reach $2.0 billion in 2017 and $3.1 billion by 2022, at a CAGR of 8.7% from 2017 to 2022. Asia-Pacific market for disposable medical sensors totaled nearly $1.5 billion in 2017 and $2.5 billion by 2......
  • Global and Chinese Dopamine Agonist Industry, 2017 Market Research Report
    Published: 04-Sep-2017        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Dopamine Agonist Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Dopamine Agonist industry with a focus on the Chinese market. The report provides key statistics on the market status of the Dopamine Agonist manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its def......
  • Substance Abuse, Addiction, and Treatment: Global Markets
    Published: 31-Aug-2017        Price: US 3950 Onwards        Pages: 150
    The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%. The drug abuse segment reached nearly $2.3 billion in 2016 and should reach $3.1 billion by 2021, at a CAGR of 6.8%. Nicotine abuse segment reached $758 million in 2016 and should reach nearly $1.1 billion by 2021, at a CAGR of 7.3%. Companies Mentioned Alkermes Plc ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs